Castle Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $86,311 | $85,782 | $87,002 | $72,974 |
Gross Profit | 86,311 | 70,173 | 69,772 | 56,395 |
EBITDA | 13,745 | 12,024 | 11,504 | 865 |
EBIT | 7,977 | 8,483 | 8,156 | -2,475 |
Net Income | 9,590 | 2,269 | 8,920 | -2,534 |
Net Change In Cash | 86,311 | 85,782 | 87,002 | 72,974 |
Free Cash Flow | 16,798 | 16,960 | 18,769 | -15,987 |
Cash | 119,709 | 94,959 | 85,572 | 82,949 |
Basic Shares | 30,200 | 29,401 | 28,738 | 27,485 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $332,069 | $219,788 | $137,039 | $94,085 |
Gross Profit | 332,069 | 174,806 | 105,030 | 78,263 |
EBITDA | 38,138 | -45,024 | -58,344 | -36,605 |
EBIT | 22,141 | -57,354 | -68,887 | -40,012 |
Net Income | 18,245 | -57,466 | -67,138 | -31,292 |
Net Change In Cash | 332,069 | 219,788 | 137,039 | 94,085 |
Free Cash Flow | 36,540 | -19,247 | -47,287 | -22,466 |
Cash | 119,709 | 98,841 | 122,948 | 329,633 |
Basic Shares | 29,255 | 26,802 | 26,054 | 25,137 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.32 |
2024-09-30 | $0.08 |
2024-06-30 | $0.31 |
2024-03-31 | -$0.09 |
